Provided by Tiger Fintech (Singapore) Pte. Ltd.

CASI Pharmaceuticals

1.94
+0.00890.46%
Post-market: 1.940.00000.00%16:05 EDT
Volume:16.80K
Turnover:34.81K
Market Cap:30.04M
PE:-0.76
High:2.20
Open:1.92
Low:1.92
Close:1.93
Loading ...

CASI Pharmaceuticals-Discontinuance of New York Litigation Proceeding & Demand for Arbitration With Respect to Dispute With Acrotech

THOMSON REUTERS
·
09 Apr

CASI Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
09 Apr

CASI Pharmaceuticals. Inc. : H.c. Wainwright Cuts Target Price to $4 From $6

THOMSON REUTERS
·
09 Apr

CASI Pharmaceuticals Acquires Precision Autoimmune Therapeutics

TIPRANKS
·
04 Apr

BRIEF-Casi Pharmaceuticals Signs Agreement To Acquire Equity Interests In Precision Autoimmune Therapeutics

Reuters
·
04 Apr

CASI Pharmaceuticals Inc: Signs Agreement to Acquire Equity Interests in Precision Autoimmune Therapeutics

THOMSON REUTERS
·
04 Apr

Casi Receives Updated Proposal From Chairman to Acquire China Business; Shares Rise

MT Newswires Live
·
03 Apr

CASI Pharmaceuticals Receives Updated Acquisition Proposal for China Operations

TIPRANKS
·
03 Apr

CASI Pharmaceuticals receives proposal to acquire China business for $20M

TIPRANKS
·
03 Apr

CASI Pharmaceuticals - Receipt of Updated Non-Binding Proposal to Acquire Entire China Business of Company

THOMSON REUTERS
·
03 Apr

CASI Pharmaceuticals - Proposed Deal for Purchase Price of $20.0 Mln

THOMSON REUTERS
·
03 Apr

CASI Pharmaceuticals Announces Receipt of An Updated Non-Binding Proposal to Acquire Entire China Business of the Company

ACCESS Newswire
·
03 Apr

CASI Pharmaceuticals Q4 Revenue USD 13.4 Million

THOMSON REUTERS
·
31 Mar

CASI Pharmaceuticals Announces Fourth Quarter and Full-Year 2024 Business and Financial Results

ACCESS Newswire
·
31 Mar

CASI Pharmaceuticals Secures Interim Relief in Juventas Dispute

TIPRANKS
·
10 Feb

This CASI Pharmaceuticals Insider Increased Their Holding By 65% Last Year

Simply Wall St.
·
06 Feb

CASI Pharmaceuticals Faces Asset Freezing Amid Arbitration Dispute

TIPRANKS
·
21 Jan

CASI Pharmaceuticals: Fourth Intermediate People S Court of Beijing Municipality, Granted Juventas Application to Freeze Co's Assets

THOMSON REUTERS
·
21 Jan

CASI Pharmaceuticals Inc: Receives Asset Freezing Order From Court of P.r. China

THOMSON REUTERS
·
21 Jan

CASI Pharmaceuticals: First Patient Dosed in Phase 1/2 Clinical Trial of Cid-103 in Immune Thrombocytopenia

THOMSON REUTERS
·
06 Jan